Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 8, 2004, Pages 737-742

  Ehehalt, R ^a   Wagenblast, J ^a   Erben, G ^a   Lehmann, W D ^a   Hinz, U ^a   Merle, U ^a   Stremmel, W ^a  

^a INF 410 ^*

Author keywords

Inflammatory bowel disease; Mucosa barrier; NanoESI MS MS; Phosphatidylcholine; Ulcerative colitis

Indexed keywords

LIPID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE; INTESTINE MUCOSA; MALE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; MUCUS; PHOSPHATIDYLCHOLINES; RECTUM; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 4143054569     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410006233     Document Type: Article

References (33)

1. Wallace JL, Granger DN. The cellular and molecular basis of gastric mucosal defense. Faseb J 1996;10:731-40.
2. Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 1995;57:565-83.
3. Allen A, Flemstrom G, Garner A, Kivilaakso E. Gastroduodenal mucosal protection. Physiol Rev 1993;73:823-57.
4. Bengmark S, Jeppsson B. Gastrointestinal surface protection and mucosa reconditioning. JPEN J Parenter Enteral Nutr 1995;19:410-5.
5. Kao YC, Lichtenberger LM. A method to preserve extracellular surfactant-like phospholipids on the luminal surface of rodent gastric mucosa. J Histochem Cytochem 1990;38:427-31.
6. Butler BD, Lichtenberger LM, Hills BA. Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. Am J Physiol 1983;244:G645-51.
7. Bernhard W, Postle AD, Linck M, Sewing KF. Composition of phospholipid classes and phosphatidylcholine molecular species of gastric mucosa and mucus. Biochim Biophys Acta 1995;1255:99-104.
8. DeSchryver-Kecskemeti K, Eliakim R, Carroll S, Stenson WF, Moxley MA, Alpers DH. Intestinal surfactant-like material. A novel secretory product of the rat enterocyte. J Clin Invest 1989;84:1355-61.
9. Ottlecz A, Romero JJ, Hazell SL, Graham DY, Lichtenberger LM. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies. Dig Dis Sci 1993;38:2071-80.
10. Weitkamp JH, Perez-Perez GI, Bode G, Malfertheiner P, Blaser MJ. Identification and characterization of Helicobacter pylori phospholipase C activity. Zentralbl Bakteriol 1993;280:11-27.
11. Foltz CJ, Fox JG, Cahill R, Murphy JC, Yan L, Shames B, et al. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 1998;3:69-78.
12. Mourelle M, Guarner F, Malagelada JR. Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. Gastroenterology 1996;110:1093-7.
13. Hills BA, Kirwood CA. Surfactant approach to the gastric mucosal barrier: protection of rats by banana even when acidified. Gastroenterology 1989;97:294-303.
14. Fabia R, Ar'Rajab A, Willen R, Andersson R, Ahren B, Larsson K, et al. Effects of phosphatidylcholine and phosphatidylinositol on acetic-acid-induced colitis in the rat. Digestion 1992;53:35-44.
15. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
16. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 2001;69:2277-85.
17. Patel B, Schutte R, Sporns P, Doyle J, Jewel L, Fedorak RN. Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. Inflamm Bowel Dis 2002;8:340-6.
18. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
19. Brugger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci USA 1997;94:2339-44.
20. Lehmann WD, Koester M, Erben G, Keppler D. Characterization and quantification of rat bile phosphatidylcholine by electro-spray-tandem mass spectrometry. Anal Biochem 1997;246:102-10.
21. Folch J, Lees GH, Sloane-Stanley A. A simple method for isolation and purification of total lipids from animal tissue. J Biol Chem 1957;226:497-509.
22. Shaw W. Possible role of lysolecithins and nonesterified fatty acids in the pathogenesis of Reye's syndrome, sudden infant death syndrome, acute pancreatitis, and diabetic ketoacidosis. Clin Chem 1985;31:1109-15.
23. McCutcheon AD. Neurological damage and duodenopancreatic reflux in the pathogenesis of alcoholic pancreatitis. Arch Surg 2000;135:278-85.
24. Madura JA. Primary bile reflux gastritis: which treatment is better, Roux-en-Y or biliary diversion? Am Surg 2000;66:417-23.
25. Shamburek RD, Schwartz CC. Selective composition of biliary phosphatidylcholines is affected by secretion rate but not by bile acid hydrophobicity. J Lipid Res 1993;34:1833-42.
26. Cantafora A, Cardelli M, Masella R. Separation and determination of molecular species of phosphatidylcholine in biological samples by high-performance liquid chromatography. J Chromatogr 1990;507:339-49.
27. Kawamoto T, Okano G, Akino T. Biosynthesis and turnover of individual molecular species of phosphatidylcholine in liver and bile. Biochim Biophys Acta 1980;619:20-34.
28. Staggers JE, Frost SC, Wells MA. Studies on fat digestion, absorption, and transport in the suckling rat. III. Composition of bile and evidence for enterohepatic circulation of bile salts. J Lipid Res 1982;23:1143-51.
29. Han X, Gross RW. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc Natl Acad Sci USA 1994;91:10635-9.
30. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. A case-control study. Scand J Gastroenterol 1987;22:1130-6.
31. Thomas GA, Rhodes J, Green JT. Inflammatory bowel disease and smoking: a review. Am J Gastroenterol 1998;93:144-9.
32. Tarnawski A, Stachura J, Gergely H, Hollander D. Gastric microvascular endothelium: a major target for aspirin-induced injury and arachidonic acid protection. An ultrastructural analysis in the rat. Eur J Clin Invest 1990;20:432-40.
33. Wilson DE. Role of prostaglandins in gastroduodenal mucosal protection. J Clin Gastroenterol 1991;13:S65-71.